Literature DB >> 12883963

Associations among awareness of prognosis, hopefulness, and coping in patients with advanced cancer participating in phase I clinical trials.

Paul R Helft1, Fay Hlubocky, Ming Wen, Christopher K Daugherty.   

Abstract

GOALS: There is considerable debate concerning prognosis in patients with advanced cancer (advanced cancer patients, ACP), but no one has systematically examined the relationship between awareness of prognosis and hopefulness. In this study, the relationships among awareness of prognosis, hopefulness, and coping were examined in a selected group of ACP. PATIENTS AND METHODS: All subjects were enrolled in phase I trials. Information was obtained from subjects via structured, face-to-face interviews. Subjects provided demographic information, answered questions designed to ascertain their awareness of their prognosis, and completed the Functional Assessment of Cancer Therapy-General instrument (FACT-G).
RESULTS: A total of 179 consecutive subjects enrolled in phase I trials were interviewed. Awareness of prognosis was assessed using a semiquantitative scale. Willingness to provide responses to the question was significantly negatively correlated with hopefulness ( r=-0.306, P=0.030). Using items from the FACT-G, hopefulness and coping were positively correlated ( r=0.140, P=0.097). Female subjects were more realistic about their prognosis than men ( b=0.568, P=0.026). More educated patients had higher response rates to the prognosis questions (OR 1.62, P<0.001), and demonstrated a more realistic awareness of prognosis ( b=0.225, P=0.030). Overall, there was a strong association between coping status and responding to the prognosis questions ( P=0.033). Patients who reported being "not at all proud of coping" had a lower response rate than patients who reported better coping. DISCUSSION: Among the ACP who provided responses, many reported an unrealistic view of their prognosis. Having a more accurate view of prognosis in the face of terminal illness was associated with reduced hopefulness, which may be related to a poorer sense of coping. Finally, the prognosis question utilized in the study was problematic, led to a fairly poor response rate, and may be indicative of the many difficulties present in attempting to accurately assess ACPs' perceptions of their prognosis. Other methods, such as in-depth qualitative methods, may lead to more productive inquiry into ACPs' awareness of their prognosis. Further research into the accurate assessment of awareness of prognosis is needed.

Entities:  

Mesh:

Year:  2003        PMID: 12883963     DOI: 10.1007/s00520-003-0496-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  36 in total

1.  How reliable are relatives' retrospective reports of terminal illness? Patients and relatives' accounts compared.

Authors:  J Hinton
Journal:  Soc Sci Med       Date:  1996-10       Impact factor: 4.634

2.  Hope in nursing research: a meta-analysis of the ontological and epistemological foundations of research on hope.

Authors:  J Kylmä; K Vehviläinen-Julkunen
Journal:  J Adv Nurs       Date:  1997-02       Impact factor: 3.187

3.  Measuring the accuracy of prognostic judgments in oncology.

Authors:  W J Mackillop; C F Quirt
Journal:  J Clin Epidemiol       Date:  1997-01       Impact factor: 6.437

4.  Clinical prediction of survival is more accurate than the Karnofsky performance status in estimating life span of terminally ill cancer patients.

Authors:  M Maltoni; O Nanni; S Derni; M P Innocenti; L Fabbri; N Riva; R Maltoni; D Amadori
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

5.  Cancer and communication: information-giving in an oncology clinic.

Authors:  P M Reynolds; R W Sanson-Fisher; A D Poole; J Harker; M J Byrne
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-02

Review 6.  Management and care of the dying patient.

Authors:  N H Cassem; R S Stewart
Journal:  Int J Psychiatry Med       Date:  1975       Impact factor: 1.210

7.  Depression, Hopelessness, and suicidal ideation in the terminally ill.

Authors:  H M Chochinov; K G Wilson; M Enns; S Lander
Journal:  Psychosomatics       Date:  1998 Jul-Aug       Impact factor: 2.386

8.  Delineating the concept of hope.

Authors:  J M Morse; B Doberneck
Journal:  Image J Nurs Sch       Date:  1995

9.  Communication between cancer patients and physicians.

Authors:  R E Hardy; D R Green; H W Jordan; G Hardy
Journal:  South Med J       Date:  1980-06       Impact factor: 0.954

10.  Cancer patients' perceptions of their disease and its treatment.

Authors:  W J Mackillop; W E Stewart; A D Ginsburg; S S Stewart
Journal:  Br J Cancer       Date:  1988-09       Impact factor: 7.640

View more
  10 in total

Review 1.  Conceptualizing prognostic awareness in advanced cancer: a systematic review.

Authors:  Allison J Applebaum; Elissa A Kolva; Julia R Kulikowski; Jordana D Jacobs; Antonio DeRosa; Wendy G Lichtenthal; Megan E Olden; Barry Rosenfeld; William Breitbart
Journal:  J Health Psychol       Date:  2013-10-24

2.  Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials.

Authors:  Rebecca D Pentz; Margaret White; R Donald Harvey; Zachary Luke Farmer; Yuan Liu; Colleen Lewis; Olga Dashevskaya; Taofeek Owonikoko; Fadlo R Khuri
Journal:  Cancer       Date:  2012-01-31       Impact factor: 6.860

3.  Unrealistic optimism in early-phase oncology trials.

Authors:  Lynn A Jansen; Paul S Appelbaum; William M P Klein; Neil D Weinstein; William Cook; Jessica S Fogel; Daniel P Sulmasy
Journal:  IRB       Date:  2011 Jan-Feb

4.  Do Patients With Advanced Cancer Have the Ability to Make Informed Decisions for Participation in Phase I Clinical Trials?

Authors:  Fay J Hlubocky; Greg A Sachs; Eric R Larson; Halla S Nimeiri; David Cella; Kristen E Wroblewski; Mark J Ratain; Jeffery M Peppercorn; Christopher K Daugherty
Journal:  J Clin Oncol       Date:  2018-07-09       Impact factor: 44.544

5.  Informed consent for pediatric phase 1 cancer trials: physicians' perspectives.

Authors:  Tsiao Yi Yap; Amy D Yamokoski; Sabahat Hizlan; Stephen J Zyzanski; Anne L Angiolillo; Susan R Rheingold; Justin N Baker; Eric D Kodish
Journal:  Cancer       Date:  2010-07-01       Impact factor: 6.860

6.  Investigator Disclosure and Advanced Cancer Patient Understanding of Informed Consent and Prognosis in Phase I Clinical Trials.

Authors:  Fay J Hlubocky; Nancy E Kass; Debra Roter; Susan Larson; Kristen E Wroblewski; Jeremy Sugarman; Christopher K Daugherty
Journal:  J Oncol Pract       Date:  2018-05-22       Impact factor: 3.840

7.  Physician factors associated with discussions about end-of-life care.

Authors:  Nancy L Keating; Mary Beth Landrum; Selwyn O Rogers; Susan K Baum; Beth A Virnig; Haiden A Huskamp; Craig C Earle; Katherine L Kahn
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

8.  Teamwork in prognostic communication: Addressing bottlenecks and barriers.

Authors:  Bryan A Sisk; Sarah Dobrozsi; Jennifer W Mack
Journal:  Pediatr Blood Cancer       Date:  2020-01-21       Impact factor: 3.167

9.  Anxiety Shapes Expectations of Therapeutic Benefit in Phase I Trials for Patients With Advanced Cancer and Spousal Caregivers.

Authors:  Fay J Hlubocky; Tamara G Sher; David Cella; Kristen E Wroblewski; Jeffery Peppercorn; Christopher K Daugherty
Journal:  JCO Oncol Pract       Date:  2021-02

10.  Epistemic Beliefs: Relationship to Future Expectancies and Quality of Life in Cancer Patients.

Authors:  Paul K J Han; Elizabeth Scharnetzki; Eric Anderson; John DiPalazzo; Tania D Strout; Caitlin Gutheil; F Lee Lucas; Emily Edelman; Jens Rueter
Journal:  J Pain Symptom Manage       Date:  2021-12-22       Impact factor: 3.612

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.